Please log in.

Lost your password?

Create an account

EPI-743 Leighs Syndrome Trial Update April 2013

April 15, 2013 by cynthia

EPI-743 is a new drug based on vitamin E and has been shown to improve the function of cells with mitochondrial problems.   For more¬†information: – a service of the U.S. National Institutes of Health Edison Pharma Lands Dainippon in Potential $545M Japan Deal  

Clinical trial for Mitochondrial Respiratory Chain Diseases

January 26, 2012 by Yurina Ichikawa

A link about the clinical trial led by Principal Investigator Dr. Gregory Enns (Stanford University). The purpose of this trial is to test the safety and efficacy of the drug, EPI-743, in patients affected with mitochondrial respiratory chain diseases. The trial is currently in phase II.